Artrya Limited (ASX:AYA)

Market Cap	77.91M
Revenue (ttm)	13.00K
Net Income (ttm)	-14.56M
Shares Out	112.92M
EPS (ttm)	-0.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	488,126
Average Volume	188,771
Open	0.6900
Previous Close	0.6800
Day's Range	0.6750 - 0.7550
52-Week Range	0.2200 - 1.0400
Beta	0.30
RSI	58.97
Earnings Date	Aug 29, 2025

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography scans which identifies and manages patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2018
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AYA